Fingerprint
Dive into the research topics of 'The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer
Brendon M. Stiles, Amit Bhargava, Prasad S. Adusumilli, Stephen F. Stanziale, Teresa H. Kim, Valerie W. Rusch, Yuman Fong
Research output: Contribution to journal › Article › peer-review
34
Scopus
citations